Literature DB >> 27371510

Advanced Heart Failure: Prevalence, Natural History, and Prognosis.

Sunit-Preet Chaudhry1, Garrick C Stewart2.   

Abstract

Heart failure is a complex clinical syndrome. The natural history of this syndrome is progressive. Advanced heart failure is present when a patient has signs and symptoms of heart failure that are refractory to therapy. Patients with the most advanced disease and worst prognosis can be identified using iterative, integrated clinical assessment of symptom burden, effort intolerance, and cardiac dysfunction. Recognizing the transition to advanced heart failure is necessary for referral to an advanced heart disease program. Advanced heart disease specialists can tailor medical therapies, perform risk stratification, and evaluate candidacy for mechanical support, transplantation, or end-of-life palliative treatment options.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiomyopathy; Clinical decision making; Heart failure; Prognosis; Risk assessment

Mesh:

Year:  2016        PMID: 27371510     DOI: 10.1016/j.hfc.2016.03.001

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN: 1551-7136            Impact factor:   3.179


  21 in total

1.  Predictors of Adherence to Self-Care in Rural Patients With Heart Failure.

Authors:  Martha J Biddle; Debra K Moser; Michele M Pelter; Susan Robinson; Kathleen Dracup
Journal:  J Rural Health       Date:  2019-12-15       Impact factor: 4.333

2.  Outcomes with moderate aortic stenosis and impaired left ventricular function: prelude to a randomized trial?

Authors:  Alexander Iribarne; Rachel M Easterwood; Ian C Bostock; Jock N McCullough
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

3.  Association of heart failure duration with clinical prognosis in advanced heart failure.

Authors:  Atsushi Sugiura; Hideki Kitahara; Togo Iwahana; Noriko Suzuki; Sho Okada; Hideyuki Miyauchi; Yoshio Kobayashi; Nikos Werner
Journal:  Clin Res Cardiol       Date:  2019-06-27       Impact factor: 5.460

4.  Patterns and predictors of dyspnoea following left ventricular assist device implantation.

Authors:  Kenneth M Faulkner; Corrine Y Jurgens; Quin E Denfeld; Christopher V Chien; Jessica Harman Thompson; Jill M Gelow; Kathleen L Grady; Christopher S Lee
Journal:  Eur J Cardiovasc Nurs       Date:  2022-10-14       Impact factor: 3.593

Review 5.  Safety and efficacy of omecamtiv mecarbil for heart failure: A systematic review and meta-analysis.

Authors:  Fadel Alqatati; Mohammad Elbahnasawy; Seif Bugazia; Khaled Mohamed Ragab; Ahmed Bostamy Elsnhory; Mostafa Shehata; Sarah Makram Elsayed; Mustafa Ali Fathy; Anas Zakarya Nourelden
Journal:  Indian Heart J       Date:  2022-03-15

Review 6.  Efficacy of tolvaptan for chronic heart failure: Study protocol for a systematic review of randomized controlled trial.

Authors:  Wei-Qin Gao; Xiang-Dong Meng; Ze Sun
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

7.  Portable Normothermic Cardiac Perfusion System in Donation After Cardiocirculatory Death: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2020-03-06

8.  Myocardial Work Assessment for the Prediction of Prognosis in Advanced Heart Failure.

Authors:  Felix Hedwig; Olena Nemchyna; Julia Stein; Christoph Knosalla; Nicolas Merke; Fabian Knebel; Andreas Hagendorff; Felix Schoenrath; Volkmar Falk; Jan Knierim
Journal:  Front Cardiovasc Med       Date:  2021-06-18

9.  User-Centered Adaptation of an Existing Heart Failure Telemonitoring Program to Ensure Sustainability and Scalability: Qualitative Study.

Authors:  Patrick Ware; Heather J Ross; Joseph A Cafazzo; Audrey Laporte; Kayleigh Gordon; Emily Seto
Journal:  JMIR Cardio       Date:  2018-12-06

Review 10.  Nanomaterials for Cardiac Tissue Engineering.

Authors:  Devang R Amin; Eric Sink; Suguna P Narayan; Mostafa Abdel-Hafiz; Luisa Mestroni; Brisa Peña
Journal:  Molecules       Date:  2020-11-07       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.